Applicant, as named in the Orange Book

Sentynl Theraps Inc

Next listed expiry: Nulibry on 9 Apr 2029. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Nulibry NDA 214018 fosdenopterin hydrobromide	fosdenopterin hydrobromide	9 Apr 2029 patent	patent
Zokinvy NDA 213969 · 2 strengths lonafarnib	lonafarnib	26 Jul 2029 patent, carve-out possible	patent, carve-out possible
Zycubo NDA 211241 copper histidinate	copper histidinate	12 Jan 2033 exclusivity	exclusivity

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.